As of 2026-09-15, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 251.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 45.35 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 454.3%.
The range of the Relative Valuation is 110.19 - 392.55 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 22.6x | 21.0x |
| Forward P/E multiples | 19.0x - 26.8x | 23.7x |
| Fair Price | 110.19 - 392.55 | 251.36 |
| Upside | 143.0% - 765.6% | 454.3% |
| Date | P/E |
| 2026-09-11 | 2.71 |
| 2026-09-10 | 2.72 |
| 2026-09-09 | 2.71 |
| 2026-09-08 | 2.72 |
| 2026-09-04 | 2.80 |
| 2026-09-03 | 2.79 |
| 2026-09-02 | 2.84 |
| 2026-09-01 | 2.73 |
| 2026-08-31 | 2.65 |
| 2026-08-28 | 2.67 |
| 2026-08-27 | 2.69 |
| 2026-08-26 | 2.67 |
| 2026-08-25 | 2.69 |
| 2026-08-24 | 2.59 |
| 2026-08-21 | 2.64 |
| 2026-08-20 | 2.60 |
| 2026-08-19 | 2.70 |
| 2026-08-18 | 2.51 |
| 2026-08-17 | 2.44 |
| 2026-08-14 | 2.45 |
| 2026-08-13 | 2.34 |
| 2026-08-12 | 2.41 |
| 2026-08-11 | 2.41 |
| 2026-08-10 | 2.39 |
| 2026-08-07 | 2.31 |
| 2026-08-06 | 2.25 |
| 2026-08-05 | 2.33 |
| 2026-08-04 | 2.22 |
| 2026-08-03 | 2.15 |
| 2026-07-31 | 2.12 |
| 2026-07-30 | 2.19 |
| 2026-07-29 | 2.25 |
| 2026-07-28 | 2.21 |
| 2026-07-27 | 2.15 |
| 2026-07-24 | 2.11 |
| 2026-07-23 | 2.12 |
| 2026-07-22 | 2.17 |
| 2026-07-21 | 2.26 |
| 2026-07-20 | 2.28 |
| 2026-07-17 | 2.33 |
| 2026-07-16 | 2.39 |
| 2026-07-15 | 2.37 |
| 2026-07-14 | 2.37 |
| 2026-07-13 | 2.37 |
| 2026-07-10 | 2.45 |
| 2026-07-09 | 2.51 |
| 2026-07-08 | 2.47 |
| 2026-07-07 | 2.45 |
| 2026-07-06 | 2.31 |
| 2026-07-02 | 2.23 |